Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Virtual Domains d: A Survey of \Inundation and Ongoing interaction Mechanics\ Computer game - 2Viable Tips for Seniors to Purchase a Minimal expense Jeep Wrangler
- 3Death toll from floods in Afghanistan rises to 61
- 4Poll: By a 2-to-1 margin, Americans say Trump has done more to raise prices than lower them
- 5Travels to Dream Objections in Europe
- The Main 15 Applications for Efficiency and Association
- When does Spotify Wrapped come out? The music streamer says 'soon.'
- SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
- Discovering a true sense of harmony: Contemplation and Care Practices
- Cells have more mini ‘organs’ than researchers thought − unbound by membranes, these rogue organelles challenge biology’s fundamentals
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- Miley Cyrus details her fear of paper, says fiancé Maxx Morando opens their packages outside: 'That's really why I got engaged'
- 5 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- Sustaining Public activity and Connections: Key Methodologies
